Appili Therapeutics Inc (APLI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 100 | 827 | 334 | 1,391 | 0 |
| Operating Expenses | 291 | 2,990 | 8,110 | 24,949 | 14,372 |
| Operating Income | -191 | -2,163 | -7,776 | -23,559 | -14,372 |
| Interest Expense | 2,953 | 1,631 | 1,096 | 1,555 | 70 |
| Other Income | 538 | 82 | -335 | 34 | 117 |
| Pre-tax Income | -2,606 | -3,711 | -9,207 | -25,080 | -14,325 |
| Income Tax | 19 | 70 | 36 | 38 | N/A |
| Net Income Continuous | -2,625 | -3,781 | -9,243 | -25,118 | -14,325 |
| Net Income | $-2,625 | $-3,781 | $-9,243 | $-25,118 | $-14,325 |
| EPS Basic Total Ops | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
| EPS Basic Continuous Ops | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
| EPS Diluted Total Ops | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
| EPS Diluted Continuous Ops | -0.02 | -0.03 | -0.08 | -0.38 | -0.24 |
| EBITDA(a) | $361 | $-2,067 | $-8,104 | $-23,512 | $-14,240 |